4.7 Article

Enaminones 8: CoMFA and CoMSIA studies on some anticonvulsant enaminones

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 17, Issue 1, Pages 133-140

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2008.11.014

Keywords

Enaminones; 3D-QSAR; CoMFA; CoMSIA; scPTZ

Funding

  1. National Institutes of Health [1R21 GM63494]
  2. RCMI Program [2 G12 RR003048]
  3. Division of Research Infrastructure
  4. National Center for Research Resources through Howard University
  5. Alliances for Graduate Education and the Professoriate (Howard University AGEP)
  6. American Foundation for Pharmaceutical Education
  7. National Institute of Neurological Disorders and Stroke
  8. NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER
  9. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM063494] Funding Source: NIH RePORTER

Ask authors/readers for more resources

3D-QSAR studies comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were carried out on 26 structurally diverse subcutaneous pentylenetetrazol (scPTZ) active enaminone analogues, previously synthesized in our laboratory. CoMFA and CoMSIA were employed to generate models to de. ne the specific structural and electrostatic features essential for enhanced binding to the putative GABA receptor. The 3D-QSAR models demonstrated a reliable ability to predict the CLogP of the active anticonvulsant enaminones, resulting in a q(2) of 0.558 for CoMFA, and a q(2) of 0.698 for CoMSIA. The outcomes of the contour maps for both models provide detailed insight for the structural design of novel enaminone derivatives as potential anticonvulsant agents. (c) 2008 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available